Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients.

Anne Sofie Brems-Eskildsen, Kristina Bak Kristoffersen, Søren Linnet, Tamás Lörincz, Sven Tyge Langkjer

Journal: Acta oncologica (Stockholm, Sweden) 2019;58(1):119-121

PMID: 30101626

Abstract

Address: a Department of Oncology , University Hospital of Aarhus , Aarhus C , Denmark.; b Department of Oncology , University Hospital of Aalborg , Aalborg , Denmark.; c Department of Oncology , Regional Hospital West Jutland , Herning , Denmark.

DOI: 10.1080/0284186X.2018.1497301

Link outs

Free resources

Medical:

https://medlineplus.gov/breastcancer.html

Other Literature Sources:

https://scite.ai/reports/30101626

Subscription / membership required

Full Text Sources:

https://www.tandfonline.com/doi/10.1080/0284186X.2...

MeSH Terms: Adult, Aged, Antineoplastic Agents, Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Female, Furans, Humans, Kaplan-Meier Estimate, Ketones, Middle Aged, Retrospective Studies, Treatment Outcome